col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Informa UK (Taylor & Francis): Expert Review of Anti-infective Therapy
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―06 Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study Mahmoud El-Bendary, Sherief abd-elsalam, Tamer Elbaz, Wafaa El-Akel, Ahmed Cordie, Tamer Elhadidy, et al. (+11)
2 [GO] 2021―Jul―06 Molecular Detections of Coronavirus: Current and Emerging Methodologies Mingkun Diao, Lang Lang, Juan Feng, Rongsong Li
3 [GO] 2021―Jun―30 The use of remdesivir for the management of patients with moderate-to-severe COVID-19: A systematic review Kaeshaelya Thiruchelvam, Chia Siang Kow, Muhammad Hadi, Syed Shahzad Hasan
4 [GO] 2021―Jun―19 Diagnosis, prevention, and treatment of coronavirus disease: a review Manoj Kumar Sarangi, Sasmita Padhi, Shrivardhan Dheeman, Santosh Kumar Karn, L. D. Patel, Dong Kee Yi, Sitansu Sekhar Nanda
5 [GO] 2021―Jun―11 Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy Sadaf Jamal Gilani, May Bin-Jumah, Muhammad Shahid Nadeem, Imran Kazmi
6 [GO] 2021―Jun―05 NSAIDs/Nitazoxanide/Azithromycin Repurposed for COVID-19: Potential Mitigation of the Cytokine Storm Interleukin-6 Amplifier via Immunomodulatory Effects Mina T. Kelleni
7 [GO] 2021―May―21 Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice Radu Crisan Dabija, Ileana Antohe, Antigona Trofor, Sabina A Antoniu
8 [GO] 2021―Apr―16 Lifestle and rehabilitation during the COVID-19 pandemic: guidance for health professionals and support for exercise and rehabilitation programs Cássia da Luz Goulart, Rebeca Nunes Silva, Murilo Rezende Oliveira, Solange Guizilini, Isadora Salvador Rocco, Vanessa Marques Ferreira Mendez, et al. (+4)
9 [GO] 2021―Apr―12 Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2 Masoumeh Sadat Mousavi Maleki, Mosayeb Restamian, Hamid Madanchi
10 [GO] 2021―Apr―09 Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management Shreya R. Savla, Kedar S. Prabhavalkar, Lokesh K. Bhatt
11 [GO] 2021―Mar―30 System for administering and monitoring hydroxychloroquine prophylaxis for COVID-19 in accordance with a national advisory: Preliminary experience of a tertiary care institute in India Praveen Kumar-M, Ritin Mohindra, Ashish Balla, Nusrat Shafiq, Vikas Suri, Deepa Kumari, et al. (+6)
12 [GO] 2021―Mar―24 Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: An observational prospective open label user survey Klang Shmuel, Megiddo Dalia, Lapidot Tair, Naparstek Yaakov
13 [GO] 2021―Mar―19 Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits Anindita Banerjee, Upasana Ganguly, Sarama Saha, Suddhachitta Chakrabarti, Reena V Saini, Ravindra K Rawal, et al. (+2)
14 [GO] 2021―Mar―15 Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials Nida Bokharee, Yusra Habib Khan, Aisha Khokhar, Tauqeer Hussain Mallhi, Nasser Hadal Alotaibi, Maria Rasheed
15 [GO] 2021―Mar―08 The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives Massimo Andreoni, Matteo Bassetti, Salvatore Corrao, Francesco Giuseppe De Rosa, Vincenzo Esposito, Marco Falcone, et al. (+6)
16 [GO] 2021―Feb―23 COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention Ashif Iqubal, Mohammad Kashif Iqubal, Farazul Hoda, Abul Kalam Najmi, Syed Ehtaishamul Haque
17 [GO] 2021―Jan―15 Potential role of glycoprotein 340 in milder SARS-CoV-2 infection in children Mohammad Zarei, Deepanwita Bose, Soheila Ali Akbari Ghavimi, Masoud Nouri-Vaskeh, Mehdi Mohammadi, Amirhossein Sahebkar
18 [GO] 2020―Dec―29 A review on favipiravir: the properties, function, and usefulness to treat COVID-19 Seyed MohammadReza Hashemian, Tayebeh Farhadi, Ali Akbar Velayati
19 [GO] 2020―Dec―23 Repurposing therapeutic agents against SARS-CoV-2 infection: most promising and neoteric progress Md. Jamal Hossain, S. M. Abdur Rahman
20 [GO] 2020―Dec―16 Exacerbation of antimicrobial resistance: another casualty of the covid-19 pandemic? Mohammed S. Razzaque
21 [GO] 2020―Dec―16 Potential Effectiveness and Adverse Implications of Repurposing Doxycycline in COVID-19 Treatment Lekshmi Narendrakumar, Iype Joseph, Sabu Thomas
22 [GO] 2020―Dec―14 The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies Zahra Payandeh, Niloufar Mohammad Khani, Mohsen Nabbi, Saeed Khalili, Masoumeh Rajabibazl, Zahra Houjaghani, Masoomeh Dadkhah
23 [GO] 2020―Dec―12 An Update on COVID-19 Pandemic: The Epidemiology, Pathogenesis, Prevention and Treatment Strategies Hin Fung Tsang, Lawrence Wing Chi Chan, William Chi Shing Cho, Allen Chi Shing Yu, Aldrin Kay Yuen Yim, Amanda Kit Ching Chan, et al. (+5)
24 [GO] 2020―Dec―03 Recent progress in the repurposing of drugs/molecules for the management of COVID-19 Divakar Sharma, Adinarayana Kunamneni
25 [GO] 2020―Nov―17 COVID-19 and inhibitors of the renin-angiotensin-aldosterone system Musaddique Hussain, Qaiser Jabeen, Fiaz-ud-Din Ahmad, Mobeen Fatima, Saira Shaukat, Abdul Majeed, et al. (+2)
26 [GO] 2020―Nov―14 Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review Betsy Ann Joseph, Mahmoud Dibas, Kirk W. Evanson, Geeta Paranjape, Charan Thej Reddy Vegivinti, Pragadeesh Thamarai Selvan, et al. (+15)
27 [GO] 2020―Nov―13 Drug repurposing: new strategies for addressing COVID-19 outbreak Pravin Shende, Bhakti Khanolkar, R.S. Gaud
28 [GO] 2020―Nov―08 Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints Mahendra Rai, Shital Bonde, Alka Yadav, Yulia Plekhanova, Anatoly Reshetilov, Indarchand Gupta, et al. (+3)
29 [GO] 2020―Oct―13 Could bacteriophages be the answer to the COVID-19 crisis? Antal Martinecz, Marcin W. Wojewodzic
30 [GO] 2020―Oct―12 Novel corona virus (COVID-19) pandemic: current status and possible strategies for detection and treatment of the disease Stuti Bhagat, Nisha Yadav, Juhi Shah, Harsh Dave, Shachee Swaraj, Shashank Tripathi, Sanjay Singh
31 [GO] 2020―Sep―14 COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment and follow up Amir Tajbakhsh, Seyed Mohammad Gheibi hayat, Hajar Taghizadeh, Ali Akbari, Masoumeh Einabadi, Amir Savardashtaki, et al. (+2)
32 [GO] 2020―Sep―12 The effect of antivirals on COVID-19: a systematic review Nafisa Hussain, Anusha Yoganathan, Savini Hewage, Samiha Alom, Amer Harky
33 [GO] 2020―Aug―27 Azithromycin in the treatment of COVID-19: a review Daniel Echeverría-Esnal, Clara Martin-Ontiyuelo, María Eugenia Navarrete-Rouco, Marta De-Antonio Cuscó, Olivia Ferrández, Juan Pablo Horcajada, Santiago Grau
34 [GO] 2020―Aug―20 COVID-19: fighting the invisible enemy with microRNA Neeraj Chauhan, Meena Jaggi, Subhash C. Chauhan, Murali M. Yallapu
35 [GO] 2020―Aug―19 MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale Paul E. Marik, Pierre Kory, Joseph Varon, Jose Iglesias, G Umberto Meduri
36 [GO] 2020―Aug―04 Resolution of coronavirus disease 2019 (COVID-19) Khaled Habas, Chioma Nganwuchu, Fanila Shahzad, Rajendran Gopalan, Mainul Haque, Sayeeda Rahman, et al. (+2)
37 [GO] 2020―Jul―30 Call for proper documentation of COVID-19 deaths in poor resource setting: a necessity for management of future occurrences Ahoma V Mbanuzuru, Chukwuemeka C Okoro, Chinyere M Mbanuzuru, Christian C Ibeh
38 [GO] 2020―Jul―24 Integrative role of traditional and modern technologies to combat COVID-19 Mohammad Heiat, Mohammad-Reza Hashemi-Aghdam, Fatemeh Heiat, Mona Rastegar Shariat Panahi, Hossein Aghamollei, Mehrdad Moosazadeh Moghaddam, et al. (+3)
39 [GO] 2020―Jul―22 Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection Marco Infante, Camillo Ricordi, Rodolfo Alejandro, Massimiliano Caprio, Andrea Fabbri
40 [GO] 2020―Jul―22 Tocilizumab for patients with severe COVID-19: a retrospective, multi-centre study Krzysztof Tomasiewicz, Anna Piekarska, Justyna Stempkowska-Rejek, Sylwia Serafińska, Aleksandra Gawkowska, Miłosz Parczewski, et al. (+6)
41 [GO] 2020―Jul―16 Loss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends George Cherry, John Rocke, Michael Chu, Jacklyn Liu, Matt Lechner, Valerie J. Lund, B. Nirmal Kumar
42 [GO] 2020―Jul―14 The Use of IV vitamin C for patients with COVID-19: a single center observational study Raul Hiedra, Kevin Bryan Lo, Mohammad Elbashabsheh, Fahad Gul, Robert Matthew Wright, Jeri Albano, et al. (+2)
43 [GO] 2020―Jul―07 Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine; from HIV-1 infection to COVID-19 Sara Naghipour, Mahsa Ghodousi, Sara Rahsepar, Sepideh Elyasi
44 [GO] 2020―Jun―23 Can nanotechnology help in the fight against COVID-19? Gabriela Palestino, Ileana García-Silva, Omar González-Ortega, Sergio Rosales-Mendoza
45 [GO] 2020―Jun―17 Repurposing minocycline for COVID-19 management: mechanisms, opportunities and challenges Harmanjit Singh, Ashish Kumar Kakkar, Prerna Chauhan
46 [GO] 2020―Jun―14 Possible therapeutic agents for COVID-19: a comprehensive review Khaled Mosaad Elhusseiny, Fatma Abd-Elshahed Abd-Elhay, Mohamed Gomaa Kamel
47 [GO] 2020―May―18 Old and re-purposed drugs for the treatment of COVID-19 Shio-Shin Jean, Po-Ren Hsueh
48 [GO] 2020―May―04 Quadruple therapy for asymptomatic COVID-19 infection patients Ling Wang, Xiaopeng Xu, Junshan Ruan, Saijin Lin, Jinhua Jiang, Hong Ye
49 [GO] 2020―Mar―29 How could artificial intelligence aid in the fight against coronavirus? Hadi M Yassine, Zubair Shah


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.006 sec